Kaleido Biosciences to collaborate with BIOASTER and MetaGenoPolis to investigate the health potential of a novel class of therapies targeting the microbiome. Kaleido Biosciences, a U.S.-based clinical-stage healthcare company, and...
Dynamiser la recherche sur le microbiote. Deux lauréats du Programme des Investissements d’Avenir (PIA), #Metagenopolis @INRA (démonstrateur pré-industriel, Lauréat 2012) et @BIOASTER (L’Institut de Recherche Technologique en microbiologie, Lauréat 2012),...
BIOASTER announces the kick off a new IMI project “GNA NOW” (Gram-Negative Antibacterials NOW), led by Evotec SE, managed by Lygature and funded by the Innovative Medicines Initiative (IMI),...
Algorithms and microbes: BIOASTER joins other IRTs to accelerate the spread of artificial intelligence in health. With the exception of image analysis, artificial intelligence (AI) in the biomedical field...
Dr Bettina Werle, Head of Protein and Expression System Engineering Unit at BIOASTER, will be attending the Virus-Like Particle & Nanoparticle Vaccines congress, in Bern as of today. She will...
June 26th&27th 2018, BIOASTER invited to join a Brazilian public-private initiative network. The University of Sao Paulo (USP), private organizations led by the Brazilian health company Eurofarma, public funders like...
BIOASTER announces today, the initiation of a collaborative project aiming at improving the safety and immunogenicity of adjuvants included in the composition of new candidate vaccines. MOSAIC (MOlecular Signatures of...
The European Commission announces the start of the TRANSVAC2 project, coordinated by the European Vaccines Initiative (EVI) in the context of the Horizon 2020 Program. This project will offer services...
Nathalie Garçon, audio interview on the blog of Neomed institute (Canada) « Bioaster, Neomed : Same Objective, Similar Approach, Some Differences » : http://blog.neomed.ca
Mass data storage and subatomic physics and astrophysics computing power are now being made available to the field of health-related and infectious disease microbiology. Lyon and Villeurbanne, February 5, 2015...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
